Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTEMRA on Inflamed Atherosclerotic Plaques in RA
NCT02659150Phase 4Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- May 2016
- Primary completion
- Nov 2019
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
01
Overview
A Phase 4 trial of tocilizumab in rheumatoid arthritis (RA), sponsored by Massachusetts General Hospital. Started May 2016; status: terminated.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02659150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02659150.